JPS5738236B2 - - Google Patents

Info

Publication number
JPS5738236B2
JPS5738236B2 JP3514973A JP3514973A JPS5738236B2 JP S5738236 B2 JPS5738236 B2 JP S5738236B2 JP 3514973 A JP3514973 A JP 3514973A JP 3514973 A JP3514973 A JP 3514973A JP S5738236 B2 JPS5738236 B2 JP S5738236B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3514973A
Other languages
Japanese (ja)
Other versions
JPS4913385A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4913385A publication Critical patent/JPS4913385A/ja
Publication of JPS5738236B2 publication Critical patent/JPS5738236B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP3514973A 1972-03-29 1973-03-29 Expired JPS5738236B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation

Publications (2)

Publication Number Publication Date
JPS4913385A JPS4913385A (en:Method) 1974-02-05
JPS5738236B2 true JPS5738236B2 (en:Method) 1982-08-14

Family

ID=5357203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3514973A Expired JPS5738236B2 (en:Method) 1972-03-29 1973-03-29

Country Status (11)

Country Link
JP (1) JPS5738236B2 (en:Method)
AT (1) AT336180B (en:Method)
BE (1) BE797512A (en:Method)
CA (1) CA999820A (en:Method)
CH (1) CH577524A5 (en:Method)
CS (1) CS167530B1 (en:Method)
DE (1) DE2315508A1 (en:Method)
FR (1) FR2178085B1 (en:Method)
GB (1) GB1429534A (en:Method)
NL (1) NL7304275A (en:Method)
SE (1) SE411905B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2621974A1 (de) * 1976-05-18 1977-11-24 Max Planck Gesellschaft Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials
JPS5836624B2 (ja) * 1978-04-05 1983-08-10 旭化成株式会社 血液処理用吸着剤
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
EP0103184B1 (en) * 1982-08-12 1990-01-17 Kanegafuchi Chemical Industry Co., Ltd. Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors
BR8304308A (pt) * 1982-08-12 1984-03-20 Diamond Shamrock Corp Membrana bioespecifica
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
HU186566B (en) * 1982-08-24 1985-08-28 Reanal Finomvegyszergyar Process for immobilisation of combinations consisting nucleofil group
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
JPH0644927B2 (ja) * 1987-03-14 1994-06-15 日本油脂株式会社 徐放性活性成分放出剤
CS277464B6 (en) * 1989-09-26 1993-03-17 Ustav Makromolekularni Chemie Contact lens made of hydrophilic gels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603393A (en:Method) * 1967-12-27 1971-04-13

Also Published As

Publication number Publication date
BE797512A (fr) 1973-07-16
NL7304275A (en:Method) 1973-10-02
CA999820A (en) 1976-11-16
FR2178085A1 (en:Method) 1973-11-09
FR2178085B1 (en:Method) 1977-04-29
JPS4913385A (en:Method) 1974-02-05
AT336180B (de) 1977-04-25
GB1429534A (en) 1976-03-24
DE2315508A1 (de) 1973-10-18
CH577524A5 (en:Method) 1976-07-15
ATA278873A (de) 1976-08-15
CS167530B1 (en) 1976-04-29
DE2315508C2 (en:Method) 1987-07-16
SE411905B (sv) 1980-02-11

Similar Documents

Publication Publication Date Title
FR2178085B1 (en:Method)
FR2192886A1 (en:Method)
FR2183488A5 (en:Method)
JPS5243363Y2 (en:Method)
JPS551837B2 (en:Method)
JPS4998311U (en:Method)
CS153919B1 (en:Method)
CS156136B1 (en:Method)
JPS4972651U (en:Method)
CS153936B1 (en:Method)
CS156588B1 (en:Method)
CS154024B1 (en:Method)
JPS4971739A (en:Method)
CH594598A5 (en:Method)
CH585385A5 (en:Method)
DD98181A1 (en:Method)
CH563039A5 (en:Method)
CH568307A5 (en:Method)
CH573279A5 (en:Method)
CH578862A5 (en:Method)
CH576549B5 (en:Method)
CH568650A5 (en:Method)
CH575946A5 (en:Method)
CH585547A5 (en:Method)
CH594644A5 (en:Method)